{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:39:14Z","timestamp":1781077154192,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013529","name":"National Lottery Community Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013529","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1053\/j.seminhematol.2026.04.002","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:59:07Z","timestamp":1776985147000},"page":"532-538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Telomere biology disorders as an example of rare disease advocacy"],"prefix":"10.1053","volume":"62","author":[{"given":"Katie Barrett","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah A.","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane K.","family":"Paxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary J.","family":"Longhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2026.04.002_bib0001","first-page":"219","article-title":"Atrophia cutis reticularis cum pigmentatione dystrophia unguium et leukoplakia oris","volume":"5","author":"Zinsser","year":"1910","journal-title":"Ikonogr Dermat Kioto"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.002_bib0002","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archderm.1930.01440070079008","article-title":"Dyskeratosis congenita with pigmentation, dystrophia unguis and leukokeratosis oris","volume":"21","author":"Cole","year":"1930","journal-title":"Arch Dermatol Syphilol"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.04.002_bib0003","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jmg.12.4.339","article-title":"Dyskeratosis congenita: clinical features and genetic aspects. Report of a family and review of the literature","volume":"12","author":"Sirinavin","year":"1975","journal-title":"J Med Genet"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.002_bib0004","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1086\/302446","article-title":"X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene","volume":"65","author":"Knight","year":"1999","journal-title":"Am J Human Genet"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.04.002_bib0005","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","article-title":"Dyskeratosis congenita in all its forms","volume":"110","author":"Dokal","year":"2000","journal-title":"Br J Haematol"},{"issue":"9324","key":"10.1053\/j.seminhematol.2026.04.002_bib0006","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(02)09087-6","article-title":"Association between aplastic anaemia and mutations in telomerase RNA","volume":"359","author":"Vulliamy","year":"2002","journal-title":"The Lancet"},{"issue":"1\u20132","key":"10.1053\/j.seminhematol.2026.04.002_bib0007","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mad.2007.10.006","article-title":"Dyskeratosis congenita: a historical perspective","volume":"129","author":"Walne","year":"2008","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.04.002_bib0008","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2141.2009.07598.x","article-title":"Advances in the understanding of dyskeratosis congenita","volume":"145","author":"Walne","year":"2009","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.002_bib0009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2003-43552","article-title":"Coats' plus: a progressive familial syndrome of bilateral Coats' disease, characteristic cerebral calcification, leukoencephalopathy, slow pre- and post-natal linear growth and defects of bone marrow and integument","volume":"35","author":"Crow","year":"2004","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.04.002_bib0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1651-2227.1970.tb08986.x","article-title":"Congenital hypoplastic thrombocytopenia and cerebral malformations in two brothers","volume":"59","author":"Hoyeraal","year":"1970","journal-title":"Acta Paediatr Scand"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.002_bib0011","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1651-2227.1988.tb10751.x","article-title":"A syndrome of progressive pancytopenia with microcephaly, cerebellar hypoplasia and growth failure","volume":"77","author":"Hreidarsson","year":"1988","journal-title":"Acta Paediatr Scand"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.04.002_bib0012","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.13442","article-title":"Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorder","volume":"170","author":"Glousker","year":"2015","journal-title":"Br J Haematol"},{"issue":"26","key":"10.1053\/j.seminhematol.2026.04.002_bib0013","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1182\/blood-2008-12-192880","article-title":"Cancer in dyskeratosis congenita","volume":"113","author":"Alter","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.04.002_bib0014","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2010.08212.x","article-title":"Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study","volume":"150","author":"Alter","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2026.04.002_bib0015","doi-asserted-by":"crossref","DOI":"10.1017\/S146239941000147X","article-title":"Variation at the TERT locus and predisposition for cancer","volume":"12","author":"Baird","year":"2010","journal-title":"Expert Rev Mol Med"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.04.002_bib0016","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood-2005-07-2622","article-title":"Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation","volume":"107","author":"Vulliamy","year":"2006","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.seminhematol.2026.04.002_bib0017","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa066157","article-title":"Telomerase mutations in families with idiopathic pulmonary fibrosis","volume":"356","author":"Armanios","year":"2007","journal-title":"N Engl J Med"},{"issue":"35","key":"10.1053\/j.seminhematol.2026.04.002_bib0018","doi-asserted-by":"crossref","first-page":"13051","DOI":"10.1073\/pnas.0804280105","article-title":"Short telomeres are a risk factor for idiopathic pulmonary fibrosis","volume":"105","author":"Alder","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.04.002_bib0019","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2011.055269","article-title":"Telomere length is associated with disease severity and declines with age in dyskeratosis congenita","volume":"97","author":"Alter","year":"2012","journal-title":"Haematologica"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.04.002_bib0020","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1183\/13993003.00308-2016","article-title":"Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive","volume":"48","author":"Newton","year":"2016","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.04.002_bib0021","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1183\/13993003.02115-2015","article-title":"Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis","volume":"48","author":"Borie","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.002_bib0022","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/hep.24304","article-title":"Telomerase mutation: a genetic risk factor for cirrhosis","volume":"53","author":"Chaiteerakij","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.002_bib0023","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hep.24173","article-title":"Constitutional telomerase mutations are genetic risk factors for cirrhosis","volume":"53","author":"Calado","year":"2011","journal-title":"Hepatology"},{"issue":"6319","key":"10.1053\/j.seminhematol.2026.04.002_bib0024","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/350569a0","article-title":"Structure and function of telomeres","volume":"350","author":"Blackburn","year":"1991","journal-title":"Nature"},{"issue":"14","key":"10.1053\/j.seminhematol.2026.04.002_bib0025","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa042980","article-title":"Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia","volume":"352","author":"Yamaguchi","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.04.002_bib0026","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bcmd.2004.12.008","article-title":"Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure","volume":"34","author":"Vulliamy","year":"2005","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.04.002_bib0027","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcmd.2006.07.001","article-title":"Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure","volume":"37","author":"Savage","year":"2006","journal-title":"Blood Cells Mol Dis"},{"issue":"6854","key":"10.1053\/j.seminhematol.2026.04.002_bib0028","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/35096585","article-title":"The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita","volume":"413","author":"Vulliamy","year":"2001","journal-title":"Nature"},{"issue":"18","key":"10.1053\/j.seminhematol.2026.04.002_bib0029","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1101\/gad.1346005","article-title":"Shelterin: the protein complex that shapes and safeguards human telomeres","volume":"19","author":"de Lange","year":"2005","journal-title":"Genes Dev"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.04.002_bib0030","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood.V91.10.3582","article-title":"Progressive telomere shortening in aplastic anemia","volume":"91","author":"Ball","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.04.002_bib0031","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V97.4.895","article-title":"Telomere length in leukocyte subpopulations of patients with aplastic anemia","volume":"97","author":"Br\u00fcmmendorf","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.002_bib0032","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.04.002_bib0033","unstructured":"Department of Health and Social Care. England Rare diseases Action Plan 2025, https:\/\/www.gov.uk\/government\/publications\/england-rare-diseases-action-plan-2025 [accessed 15.11.25]."},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.002_bib0034","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/nprot.2006.263","article-title":"Flow cytometry and FISH to measure the average length of telomeres (flow FISH)","volume":"1","author":"Baerlocher","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1053\/j.seminhematol.2026.04.002_bib0035","series-title":"GeneReviews\u00ae","article-title":"Dyskeratosis congenita and related telomere biology disorders","author":"Savage","year":"1993"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.04.002_bib0036","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00439-021-02257-4","article-title":"High-throughput STELA provides a rapid test for the diagnosis of telomere biology disorders","volume":"140","author":"Norris","year":"2021","journal-title":"Hum Genet"},{"issue":"11","key":"10.1053\/j.seminhematol.2026.04.002_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113747","article-title":"Direct comparison of flow-FISH and qPCR as diagnostic tests for telomere length measurement in humans","volume":"9","author":"Gutierrez-Rodrigues","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.04.002_bib0038","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3390\/ijms18081765","article-title":"Correlation of leukocyte telomere length measurement methods in patients with dyskeratosis congenita and in their unaffected relatives","volume":"18","author":"Khincha","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.002_bib0039","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/nyas.14248","article-title":"Comparison of flow-FISH and MM-qPCR telomere length assessment techniques for the screening of telomeropathies","volume":"1466","author":"Ferreira","year":"2020","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.04.002_bib0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41576-022-00527-z","article-title":"Genetics of human telomere biology disorders","volume":"24","author":"Revy","year":"2023","journal-title":"Nat Rev Genet"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.04.002_bib0041","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1182\/blood.2021013523","article-title":"Disease progression and clinical outcomes in telomere biology disorders","volume":"139","author":"Niewisch","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.002_bib0042","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/hematology.2023000490","article-title":"Clinical manifestations of telomere biology disorders in adults","volume":"2023","author":"Niewisch","year":"2023","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.04.002_bib0043","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/bloodadvances.2024014632","article-title":"Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort","volume":"9","author":"Tometten","year":"2025","journal-title":"Blood Adv"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.04.002_bib0044","first-page":"797","article-title":"Diagnosis and management of adult telomere biology disorders","volume":"111","author":"Franke","year":"2026","journal-title":"Haematologica"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.002_bib0045","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.chest.2024.06.006","article-title":"Clinical impact of telomere length testing for interstitial lung disease","volume":"166","author":"Zhang","year":"2024","journal-title":"Chest"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.04.002_bib0046","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cld.2025.03.001","article-title":"Telomere disorders and the liver","volume":"29","author":"Calleri","year":"2025","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.seminhematol.2026.04.002_bib0047","unstructured":"Team Telomere. Telomere biology disorders: diagnosis and management guidelines, Second Edition, https:\/\/teamtelomere.org\/diagnosis-management-guidelines\/ [accessed 15.11.25]."},{"key":"10.1053\/j.seminhematol.2026.04.002_bib0048","unstructured":"Team Telomere. One-pager resources, https:\/\/teamtelomere.org\/one-pager-resources\/ [accessed 15.11.25]."},{"key":"10.1053\/j.seminhematol.2026.04.002_bib0049","unstructured":"DC Action. Symptoms & information for GPs, https:\/\/dcaction.org\/patient-resources\/symptoms-information-for-gps\/ [accessed 15.11.25]."},{"key":"10.1053\/j.seminhematol.2026.04.002_bib0050","unstructured":"DC Action. Cheat sheets by speciality, https:\/\/dcaction.org\/patient-resources\/cheat-sheets-by-speciality\/ [accessed 15.11.25]."},{"key":"10.1053\/j.seminhematol.2026.04.002_bib0051","unstructured":"Team Telomere. Centers of excellence, https:\/\/teamtelomere.org\/centers-of-excellence\/ [accessed 15.11.25]."},{"issue":"12","key":"10.1053\/j.seminhematol.2026.04.002_bib0052","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/s41431-024-01697-6","article-title":"Defining the complex needs of families with rare diseases-the example of telomere biology disorders","volume":"32","author":"Wilsnack","year":"2024","journal-title":"Eur J Hum Genet"},{"key":"10.1053\/j.seminhematol.2026.04.002_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.ssmqr.2024.100486","article-title":"A \"rotating menu\" of medical uncertainty for families affected by telomere biology disorders: a qualitative interview study","volume":"6","author":"Pearce","year":"2024","journal-title":"SSM Qual Res Health"},{"key":"10.1053\/j.seminhematol.2026.04.002_bib0054","doi-asserted-by":"crossref","DOI":"10.2196\/64343","article-title":"\u201cCrying in the wilderness\u201d-the use of web-based support in telomere biology disorders: thematic analysis","volume":"8","author":"Pearce","year":"2024","journal-title":"JMIR Form Res"},{"key":"10.1053\/j.seminhematol.2026.04.002_bib0055","doi-asserted-by":"crossref","DOI":"10.2196\/46693","article-title":"The use of social Media to express and manage medical uncertainty in dyskeratosis congenita: content analysis","volume":"4","author":"Pearce","year":"2024","journal-title":"JMIR Infodemiol"},{"key":"10.1053\/j.seminhematol.2026.04.002_bib0056","first-page":"29","article-title":"Hematopoietic cell transplantation without radiation or DNA alkylating agents in bone marrow failure with short telomeres","volume":"54","author":"Agarwal","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.002_bib0057","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1182\/hematology.2023000470","article-title":"Minimal intensity conditioning strategies for bone marrow failure: is it time for \"preventative\" transplants?","volume":"2023","author":"Agarwal","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Prog"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.002_bib0058","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000874","article-title":"Identification of adult patients with classical dyskeratosis congenita or cryptic telomere biology disorder by telomere length screening using age-modified criteria","volume":"7","author":"Tometten","year":"2023","journal-title":"Hemasphere"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:53:41Z","timestamp":1781027621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196326000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0037196326000284"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.04.002","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telomere biology disorders as an example of rare disease advocacy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}